The Effect of Time-restricted Feeding on Physiological Function in Middle-aged and Older Adults
Status: | Recruiting |
---|---|
Conditions: | Healthy Studies |
Therapuetic Areas: | Other |
Healthy: | No |
Age Range: | 55 - 79 |
Updated: | 4/17/2018 |
Start Date: | April 2016 |
End Date: | January 2019 |
Contact: | Christopher R Martens, Ph.D. |
Email: | christopher.martens@colorado.edu |
Phone: | 3034922485 |
The purpose of this study is to assess the safety and efficacy of time-restricted feeding
(eating within an 8-hour window) for improving physiological function (vascular, motor,
cognitive and metabolic function) in healthy middle-aged and older adults.
(eating within an 8-hour window) for improving physiological function (vascular, motor,
cognitive and metabolic function) in healthy middle-aged and older adults.
Overall, the proposed research project has the long-term potential to influence clinical
practice by establishing novel therapies for treating multiple domains of age-associated
physiological dysfunction and thereby reducing the risk of clinical disease and disability.
practice by establishing novel therapies for treating multiple domains of age-associated
physiological dysfunction and thereby reducing the risk of clinical disease and disability.
Inclusion Criteria:
- Ability to provide informed consent
- Baseline brachial flow-mediated dilation (FMD) < 6%Δ (rationale: non-invasive
screening to ensure exclusion of subjects with exceptionally high baseline endothelial
function.
- Ability to perform motor and cognitive tests (e.g., can rise from a chair, walk for 2
min, climb 10 stairs)
- Women will be confirmed as postmenopausal (either natural or surgical) based on
cessation of menses for >1 year.
Exclusion Criteria:
- Ages <55 years or ≥80 years
- Occupation that requires night-shift work or abnormal hours that would disrupt eating
schedule
- Dietary habit of regularly skipping meals, already eating within a ~10 hour window, or
any other form of restrictive eating.
- Unable to adhere to an 8 hour eating window for the length of the study period
- Participation in regular vigorous aerobic/endurance exercise (>3 vigorous bouts/week)
- Not weight stable in the prior 3 months (>2 kg weight change).
- Body mass index (BMI) >40 kg/m^2 (rationale: vascular function measurements can be
inaccurate in severely obese subjects)
- Current smoking
- Diagnosis of a chronic clinical disease (e.g., coronary artery/peripheral
artery/cerebrovascular diseases, diabetes, chronic kidney disease requiring dialysis,
neurological disorders or diseases that may affect motor/cognitive functions [multiple
sclerosis, Parkinson's disease, polio, Alzheimer's disease, dementia or other brain
diseases of aging]), except hypertension and hyperlipidemia.
- Having unstable angina, acute myocardial infarction, coronary angioplasty, or aorto-
coronary bypass surgery as defined by the occurrence of an event, symptom, surgery, or
change in medication and/or dosage within 3 months prior to enrollment.
- Having thyroid disease that is not controlled by medications or <3 month's use of a
particular medication and/or dosage (rationale: uncontrolled thyroid diseases are
associated with alterations in vascular function).
- Having past or present alcohol dependence or abuse, as defined by the American
Psychiatry Association, Diagnostic and Statistical Manual of Mental Disorders
We found this trial at
1
site
Click here to add this to my saved trials